(Q39782710)

14 September 2017

1 reference

title

Prostaglandins as modulators of pain (English)

1 reference

14 September 2017

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

8 April 2023

author name string

H. Juan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A365674

8 April 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=365674

8 April 2023

publication date

1 January 1978

1 reference

full work available at URL

14 September 2017

https://api.elsevier.com/content/article/PII:0306362378900253?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

https://api.elsevier.com/content/article/PII:0306362378900253?httpAccept=text/plain

8 April 2023

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

8 April 2023

1 reference

14 September 2017

9

1 reference

14 September 2017

403-409

1 reference

14 September 2017

6

1 reference

Bradykinin and serotonin effects on various types of cutaneous nerve fibers.

14 September 2017

2

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

The effects of bradykinin and prostaglandin E1 on rat cutaneous afferent nerve activity

8 April 2023

3

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Antagonism by aspirin and fenamates of bronchoconstriction and nociception induced by adenosine-5'-triphosphate.

8 April 2023

4

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Nociceptive Response to Prostaglandins and Analgesic Actions of Aspirin and Morphine

8 April 2023

6

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Cutaneous reactions to intradermal prostaglandins

8 April 2023

7

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Release of prostaglandins and their precursors by bradykinin

8 April 2023

8

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Synthetic High Molecular Weight Enzyme Inhibitors. I. Polymeric Phosphates of Phloretin and Related Compounds

8 April 2023

9

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine.

8 April 2023

10

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Prostaglandins, Aspirin-like Drugs and Analgesia

8 April 2023

12

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Indomethacin and aspirin abolish prostaglandin release from the spleen

8 April 2023

14

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs

8 April 2023

15

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

The effect of histamine, 5-hydroxytryptamine and acetylcholine on cutaneous afferent fibres

8 April 2023

18

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Uterus relaxation by highly potent Ca plus,plus-antagonistic inhibitors of electro-mechanical coupling such as Isoptin (verapamil, iproveratril), compound D 600 and Segontin (prenylamine). Experiments on the isolated virgin rat uterus

8 April 2023

19

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

The importance of phospholipase-A2 in prostaglandin biosynthesis

8 April 2023

20

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Muscle receptors with group IV afferent fibres responding to application of bradykinin

8 April 2023

21

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Prostaglandin-oxytocin enhancement and potentiation and their clinical applications.

8 April 2023

22

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

VASCULAR REFLEX RESPONSES INDUCED BY AN INTRAARTERIAL INJECTION OF AZAAZEPINOPHENOTHIAZINE, ANDROMEDOTOXIN, VERATRIDINE, BRADYKININ AND KALLIKREIN AND BLOCKING ACTION OF SODIUM SALICYLATE

8 April 2023

25

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Action of Prostaglandin E1 on Tissues which respond to Bradykinin

8 April 2023

26

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Mechanism of action of bradykinin-induced release of prostaglandin E

8 April 2023

28

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Inhibition of the algesic effect of bradykinin and acetylcholine by mepacrine

8 April 2023

29

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Action of peptides and other algesic agents on paravascular pain receptors of the isolated perfused rabbit ear

8 April 2023

32

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Inhibition of the action of bradykinin and acetylcholine on paravascular pain receptors by tetrodotoxin and procaine

8 April 2023

35

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Release of prostaglandins from the isolated perfused rabbit ear by bradykinin and acetylcholine

8 April 2023

36

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Polyphloretin phosphate reduces the algesic action of bradykinin by interfering with E-type prostaglandins

8 April 2023

37

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Prostaglandin F2alpha reduces the algesic effect of bradykinin by antagonizing the pain enhancing action of endogenously released prostaglandin E.

8 April 2023

40

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Action of prostaglandin in the pregnant woman

8 April 2023

42

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Interaction of prostaglandins and indomethacin with algesic substances

8 April 2023

45

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Lack of algesic effect of substance P on paravascular pain receptors

8 April 2023

46

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Influence of changed calcium and potassium concentration on the algesic effect of bradykinin and acetylcholine

8 April 2023

47

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Release of prostaglandins by bradykinin as an intrinsic mechanism of its algesic effect

8 April 2023

48

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

SITE OF ACTION OF NARCOTIC AND NON-NARCOTIC ANALGESICS DETERMINED BY BLOCKING BRADYKININ-EVOKED VISCERAL PAIN

8 April 2023

52

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Release of a Prostaglandin E-Like Substance from Canine Kidney by Bradykinin

8 April 2023

53

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

The presence of a kinin in inflammatory synovial effusion from arthritides of varying etiologies

8 April 2023

54

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Activation of group IV afferent units from muscle by algesic agents

8 April 2023

55

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Inhibition of prostaglandin biosynthesis as the mechanism of analgesia of aspirin-like drugs in the dog knee joint

8 April 2023

59

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Hormone interactions in the isolated rabbit heart. Synthesis and coronary vasomotor effects of prostaglandins, angiotensin, and bradykinin

8 April 2023

60

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Release of rabbit aorta contracting substance (RCS) and prostaglandins induced by chemical or mechanical stimulation of guinea-pig lungs

8 April 2023

61

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Visceral Pain evoked by Intra-Arterial Injection of Substance P

8 April 2023

62

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Bradykinin-induced coronary chemoreflex in the dog

8 April 2023

64

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Release of pharmacologically active substances from the rat skin in vivo following thermal injury

8 April 2023

65

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Prostaglandins and anti-inflammatory drugs in the dog knee joint.

8 April 2023

66

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Aspirin selectively inhibits prostaglandin production in human platelets

8 April 2023

69

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Letter: Prostaglandins as regulators of bradykinin responses

8 April 2023

71

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Prostaglandins, kinin and inflammation in the rat.

8 April 2023

72

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

8 April 2023

73

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Selective inhibition by mepacrine of the release of "rabbit aorta contracting substance" evoked by the administration of bradykinin

8 April 2023

75

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Repeated injection of prostaglandin E2 in rat paws induces chronic swelling and a marked decrease in pain threshold

8 April 2023

76

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

Effects of prostaglandins PGF2a and PGE1 on vascular permeability

8 April 2023

78

1 reference

https://api.crossref.org/works/10.1016/0306-3623(78)90025-3

8 April 2023

Identifiers

1 reference

release_2ijci5ppzfcv7dqzxmrhyshoq4

14 September 2017

0 references

1 reference